Skip to main content
Book cover

HIV-1 Latency

  • Book
  • © 2018

Overview

  • Offers new insights into the fascinating area of HIV latency and persistence from multiple perspectives and scientific directions
  • Provides in-depth analyses of current concepts, paradigms and ideas that drive the HIV-1 cure agenda
  • Identifies areas that require specific emphasis in future studies

Part of the book series: Current Topics in Microbiology and Immunology (CT MICROBIOLOGY, volume 417)

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (9 chapters)

Keywords

About this book

This volume summarizes recent advances in understanding the mechanisms of HIV-1 latency, in characterizing residual viral reservoirs, and in developing targeted interventions to reduce HIV-1 persistence during antiretroviral therapy. Specific chapters address the molecular mechanisms that govern and regulate HIV-1 transcription and latency; assays and technical approaches to quantify viral reservoirs in humans and animal models; the complex interchange between viral reservoirs and the host immune system; computational strategies to model viral reservoir dynamics; and the development of therapeutic approaches that target viral reservoir cells. With contributions from an interdisciplinary group of investigators that cover a broad spectrum of subjects, from molecular virology to proof-of-principle clinical trials, this book is a valuable resource for basic scientists, translational investigators, infectious-disease physicians, individuals living with HIV/AIDS and the general public.


Editors and Affiliations

  • School of Medicine, Emory University, Atlanta, USA

    Guido Silvestri

  • The Brigham and Women’s Hospital and the Ragon Institute of MGH, MIT and Harvard, Boston, USA

    Mathias Lichterfeld

About the editors

Guido Silvestri

Emory University School of Medicine, Atlanta, GA 30329, USA

gsilves@emory.edu




Mathias Lichterfeld

The Brigham and Women’s Hospital and the Ragon Institute of MGH, MIT and Harvard, Boston, MA, USA

MLICHTERFELD@mgh.harvard.edu




Bibliographic Information

Publish with us